IRIS International to Present NADiA ProsVue at Two Important Meetings in Washington DC Addressing the Role of Advanced Diagnostics in Cancer
20 sept. 2012 08h00 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., Sept. 20, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high...
IRIS International Announces Agreement to be Acquired by Danaher Corporation for $19.50 per Share
17 sept. 2012 08h22 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., Sept. 17, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high...
IRIS International Announces Second Quarter 2012 Revenue and Financial Results
31 juil. 2012 16h05 HE
|
IRIS International, Inc.
Record revenue of $30.9 million in Q2 2012; 2% growth over Q2 2011
Gross margin of 54% in Q2 2012
GAAP EPS of $0.07 in Q2 2012
Reaffirming 2012 guidance of revenues in a range from...
IRIS to Release Second Quarter Financial Results and Host Conference Call and Webcast on Tuesday, July 31
19 juil. 2012 16h05 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., July 19, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables and a provider of...
IRIS International Announces Distribution Agreement With Alifax and Launch of ESR Automated Instrumentation
17 juil. 2012 17h30 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., July 17, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables and a provider of...
IRIS International Announces Clinical Data Presentation of NADiA(R) ProsVue(TM) Benefits at the 5th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer
06 juin 2012 18h21 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., June 6, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables and a provider of...
IRIS International to Present at Upcoming Investor Conferences
25 mai 2012 10h41 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., May 25, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables and a provider of...
IRIS International Unveils NADiA(R) ProsVue(TM) at the American Urological Association (AUA) Annual Meeting, May 19-24, 2012
21 mai 2012 08h30 HE
|
IRIS International, Inc.
Test Identifies Patients at Reduced Risk for Prostate Cancer Clinical Recurrence After Surgery
CHATSWORTH, Calif., May 21, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a...
IRIS International Announces First Quarter 2012 Revenue and Financial Results
02 mai 2012 16h05 HE
|
IRIS International, Inc.
Record revenue of $29.9 million in Q1 2012; 11% growth over Q1 2011
Gross margin of 53% in Q1 2012
GAAP EPS of $0.05 in Q1 2012
Reaffirming 2012 guidance of revenues in a range from...
IRIS to Release First Quarter Financial Results and Host Conference Call and Webcast on Wednesday, May 2, 2012
13 avr. 2012 16h10 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., April 13, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a developer of...